These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15821005)

  • 1. Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention.
    Arakawa K; Kawai Y; Kumamoto T; Morikawa N; Yoshida M; Tada H; Kawaguchi R; Taniguchi K; Miyamori I; Kominato Y; Kishi K; Yasuda T
    Eur Heart J; 2005 Nov; 26(22):2375-80. PubMed ID: 15821005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum deoxyribonuclease I can be used as a useful marker for diagnosis of death due to ischemic heart disease.
    Yasuda T; Iida R; Kawai Y; Nakajima T; Kominato Y; Fujihara J; Takeshita H
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S213-5. PubMed ID: 19254870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.
    Bar-Or D; Winkler JV; Vanbenthuysen K; Harris L; Lau E; Hetzel FW
    Am Heart J; 2001 Jun; 141(6):985-91. PubMed ID: 11376314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
    Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
    Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction.
    Kawai Y; Yoshida M; Arakawa K; Kumamoto T; Morikawa N; Masamura K; Tada H; Ito S; Hoshizaki H; Oshima S; Taniguchi K; Terasawa H; Miyamori I; Kishi K; Yasuda T
    Circulation; 2004 May; 109(20):2398-400. PubMed ID: 15148274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test.
    Morikawa N; Kawai Y; Arakawa K; Kumamoto T; Miyamori I; Akao H; Kitayama M; Kajinami K; Lee JD; Takeshita H; Kominato Y; Yasuda T
    Eur Heart J; 2007 Dec; 28(24):2992-7. PubMed ID: 17967825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.
    Prasad A; Singh M; Lerman A; Lennon RJ; Holmes DR; Rihal CS
    J Am Coll Cardiol; 2006 Nov; 48(9):1765-70. PubMed ID: 17084247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum deoxyribonuclease I activity can be a useful diagnostic marker for the early diagnosis of unstable angina pectoris or non-ST-segment elevation myocardial infarction.
    Fujibayashi K; Kawai Y; Kitayama M; Akao H; Ishida R; Motoyama A; Wakasa M; Arakawa K; Ueki M; Kajinami K; Yasuda T
    J Cardiol; 2012 May; 59(3):258-65. PubMed ID: 22365949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K
    J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemia-modified albumin elevation after percutaneous coronary intervention reflects albumin concentration rather than ischaemia.
    Demir H; Topkaya BC; Erbay AR; Dogan M; Yücel D
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):327-31. PubMed ID: 19487408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention in the context of systemic inflammation: more injury and worse outcome.
    Saadeddin SM; Habbab MA
    Med Sci Monit; 2003 Aug; 9(8):RA193-7. PubMed ID: 12942045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicorandil suppressed myocardial injury after percutaneous coronary intervention.
    Isono T; Kamihata H; Sutani Y; Motohiro M; Yamamoto S; Kyoui S; Iharada Y; Kurimoto K; Hara K; Takahashi H; Iwasaka T
    Int J Cardiol; 2008 Jan; 123(2):123-8. PubMed ID: 17346816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of plasma brain natriuretic peptide to serum creatine kinase MB level in patients with acute myocardial infarction following primary percutaneous coronary intervention].
    Xiao ZH; Yang XL; Tan HB; Chen J; Xu ZY; Zhang JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1665-6. PubMed ID: 17121728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.